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2Abstract
The understanding of mutagenic potency has been primarily approached using 
"quantitative structure activity relationships" (QSAR).  Often this method allows the 
prediction of mutagenic potency of the compound based on its structure.  But it does not 
give the underlying reason why the mutagenic activities differ.  We have taken a set of 
heterocyclic amine structures and used molecular dynamic calculations to dock these 
molecules into the active site of a computational model of the cytochrome P-450 1A1 
enzyme.  The calculated binding strength using Boltzman distribution constants was then 
compared to the QSAR value (HF/6-31G* optimized structures) and the 
Ames/Salmonella mutagenic potency.  Further understanding will only come from 
knowing the complete set of mutagenic determinants.  These include the nitrenium ion 
half-life, DNA adduct half-life, efficiency of repair of the adduct, and ultimately fixation 
of the mutation through cellular processes.  For two isomers, PhIP and 3-Me-PhIP, we 
showed that for the 100-fold difference in the mutagenic potency a 5-fold difference can 
be accounted for by differences in the P450 oxidation.  The other factor of 20 is not 
clearly understood but is downstream from the oxidation step.  The application of QSAR 
(chemical characteristics) to biological principles related to mutagenesis is explored in 
this report.
3Introduction
In identifying the compounds responsible for the mutagenic potency of cooked meats, a 
series of aromatic amines were synthesized at Lawrence Livermore National Laboratory, 
USA [1], in  Japan [2] and in Sweden [3].  Early on, it was surprising to note that small 
changes in molecule structure had a large impact on mutagenic potency in the 
Ames/Salmonella test.  This was especially apparent in the frameshift sensitive 
Salmonella strains TA1538 and TA98 [4,5].  More than 20 mutagenic aromatic amines 
have been identified from food and additional closely-related structural analogs and 
isomers have been synthesized to do structure-activity studies. 
Mutagenic Potency of Cooked-Food Mutagens
There are two classes of aromatic amines related to cooked food mutagens: amino-
carbolines, and amino-imidazoazaarenes (AIA).  A group of 23 amino carbolines were 
evaluated for mutagenicity with a resulting range in mutagenic potency of over 200,000-
fold.  These studies found that potency depended on the presence and position of a 
pyridine-type nitrogen in one of the rings, the position of the amino group, and the 
methyl substitutions on ring carbon atoms [6].  The AIA class of mutagens comprises the 
most prevalent mutagenic compounds in well-done meat, and is therefore the most 
relevant for human exposures from foods. This class of mutagens is derived from creatine 
(a constituent of muscle), which contributes the amino group on the 2-carbon of the 
imidazole ring common to these AIAs.  These AIAs have mutagenic potencies ranging 
4.8 million-fold as seen in Figure 1. Three of the most commonly studied AIAs, PhIP, 
4MeIQx, and IQ, are found in well-done meat.  The structural parameters that determine 
their mutagenic potency were determined to be: the number of fused rings, the number of 
heteroatoms in the non-imidazole ring, N-methyl substitution on the imidazole ring, and 
methyl substitution on ring carbon atoms [6]. Figure 1 shows the more potent compounds 
have a heteroatom in the non-imidazole ring and have an N-methyl group.  Although the 
chemical attributes of the mutagens can be defined, how this relates to the biology of 
mutagenesis is largely unanswered. 
A set of eleven amino-trimethyimidazopyridine (TMIP) isomers, ranging 600-fold in 
mutagenic potency, were examined using computational methods. The principal 
determinants of higher mutagenic potency in these isomeric amines are: (1) a small 
dipole moment, (2) the combination of ring fusion and having the N3-methyl group, (3) a 
lower calculated energy of the pi electron system (4), a smaller energy gap between the 
highest and lowest unoccupied molecular orbitals of the amine (5), and a more stable 
nitrenium ion [7].
A study of the relationship between the mutagenic potency in the Ames test and the 
carcinogenic potency in rodents of 34 aromatic amines shows that there is a significant 
quantitative relationship (R=0.66 P<0.001) between the two measurements after the 
results are translated into the appropriate quantitative terms [8].  Again, the chemical 
parameters of the number of rings in the compound and methyl substitutions at carbon 
atoms were important determinants in the carcinogenic potencies.  These structure-
activity studies were extended to the evaluation of electronic and hydropathic factors for 
580 amines, and the main determinant of mutagenicity was the extent of the pi electron 
system, with smaller contributions from dipole moment, the calculated stability of the 
nitrenium ion, and hydrophobicity [9].
Mutagenicity of Two PhIP Isomers
The importance of the position of the N-methyl group of PhIP is a good case study.  The 
mutagenic potency of PhIP (methyl group at the 1-position) and its 3-Me-PhIP isomer 
differs by ~100-fold in the Ames/Salmonella assay (Figure 2A).  None of the calculated 
chemical parameters mentioned above would explain the differences seen between these 
two isomers.  We hypothesized that the slight differences in structure are important for 
interaction of the compound with the enzyme active sites for oxidation or further phase II 
enzymatic conjugation (see Figure 2B). The data in Figure 2C shows that the slower 
oxidation step (conversion of the PhIP isomers to their N-OH intermediate) from the 3-
Me-PhIP isomer accounts for approximately 5-fold of the 100-fold difference in potency 
for the mutagenicity. The remaining 20-fold difference can be seen clearly by the 
mutagenic potency of the NOH derivates in the Ames/Salmonella test (Figure 2D). 
Further experimental investigation of the reasons for these differences in mutagenic 
potency will be difficult, but should be done.  Differences in the stability of the reactive 
intermediates, and how they fit into the N-acetyltransferase or Sulfotransferase active 
sites may impact further activation. Stability of the adduct, removal of the adduct (see 
discussion below), and specificity for base targets in the histidinol dehyrogenase gene, 
may all impact the mutagenic potency.  
6Enzyme Activity Can Affect Mutagenic Potential
One informative study from our laboratory has shown that DNA binding of PhIP in 
human intestine is dependent primarily on both cytochrome P4501A2 oxidation and 
conjugation by phase II enzymes [10]. The premise of these studies was to relate 
phenotypic and genotypic differences for these activities in the patients with quantitative 
DNA binding measurement after PhIP exposure.  In addition, the amount of UDP-
glucuronosyl transferase (UDPGT)–mediated N2 glucuronidation of NOH-PhIP was 
measured by analysis of the glucuronide conjugates in the urine of the patients. The study 
revealed that individuals with high levels of urinary NOH-PhIP-N2-glucuronide and a fast 
cytochrome P4501A2 phenotype were more protected against DNA adducts and 
presumably mutations, compared to individuals with low urinary NOH-PhIP-N2-
glucuronide and a slow cytochrome P4501A2 phenotype.  We proposed that the UDPGT 
glucuronidation at the N2 position detoxifies the NOH-PhIP intermediate making it 
unavailable for further activation and DNA damage [10].
Computer Modeling 
Another way to understand the importance of small structural changes on mutagenic 
potential is to study the computer docking of metabolite intermediates into the enzyme 
active sites of Phase II activating enzymes.  Recently, Lau et al. investigated the ability of 
various heterocyclic amine reactive intermediates to fit into the N-acetyltransferase 
(NAT2) active-site [11].  Using a NAT2 homology model constructed from available 
crystal structures, docking studies and quantum mechanical calculations of hydroxylated 
heterocyclic amines revealed that the observed differences in mutagenic activity between 
7NOH-PhIP and NOH-MeIQ are not related to their acetylation reaction with NAT2.  
These results suggest that other metabolic steps or steps in the DNA adduct formation 
and/or repair process may be involved in determining the mutagenic potential of these 
compounds.  
DNA Repair Affects Mutagenic Potency
The ability to repair the initial adduct or damage is also important for determining a 
compound’s mutagenic potency.  For heterocyclic amines the 3’ cutting step of 
nucleotide excision repair (XPG) appears to play an important role in repair of DNA 
damage.  Figure 3 shows a number of CHO cell lines with mutant repair genes and their 
impact on cell killing. The XPG mutant has not only a large impact on survival, but also 
remarkably increased mutation frequency when exposed to NOH PhIP (data not shown).  
Experiments to understand the role of chemical structure on the incision efficiency at the 
3’ and 5’ sites for these bulky adducts formed from heterocyclic amine exposure would 
greatly increase our understanding of the repair process for these types of chemicals.  
Clearly, whether the adduct is in the major groove or the minor groove of DNA will 
impact the efficiency of repair.  What is not known is how small isomeric differences in 
the heterocyclic amines impact the structure of the DNA adduct and how that relates to 
mutagenic potency.  Of course the polymerase will also play a role in the nucleotide 
excision repair process, but again, do these small changes in structure impact this step 
leading to the observed differences in mutagenic potency?
QSAR Studies
8A number of QSAR studies of the AIA food mutagens have found that high mutagenic 
potency is predicted by low-energy lowest unoccupied molecular orbital (LUMO) 
[12,13].  Our results show a reasonably strong correlation between LUMO energy and 
observed mutagenic potential of several heterocyclic amine mutagens (Figure 4).  A 
lower LUMO energy means a higher electron affinity. Using the reasoning that electron 
withdrawing groups should lead to lower LUMO energies, two novel, highly mutagenic 
heterocyclic amine analogs have been proposed. For each compound the optimized 
structure and LUMO energies using ab initio quantum chemical methods were calculated.  
Using the linear relationship between LUMO energy and log mutagenic potency it was 
possible to extrapolate and predict the potencies of these novel compounds. 
Conclusions
Understanding the cancer risk of human exposure to heterocyclic amines is a challenging 
problem because the compounds vary widely in potency and quantities present in the diet.  
Adding to this complex problem is the knowledge that these compounds occur as 
mixtures of varying ratios in cooked meats.  Still, the majority of human epidemiology 
studies suggest that exposure to heterocyclic amines may be involved in the development 
of tumors at multiple sites in humans, including breast, colon and stomach[14].
This discussion points out that there is a lack of understanding of the important biological 
pathways leading to mutation for compounds like heterocyclic amines.  Clearly, the first 
step in metabolism is important, but for the PhIP isomers it only explains 20% of the 
difference.  Stability of the intermediates and adducts, efficiency of repair, conversion to 
9more active leaving groups (possibly nitrenium ions) may all be important.  Our 
understanding of how the chemical criteria, like dipole moment, a lower calculated 
energy of the pi electron system, and/or a smaller energy gap between the amine’s 
highest and lowest unoccupied molecular orbitals, impacts mutagenic potency is an 
important effort for future research.
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Figure Legend 
Figure 1.  Chemical structure and common name of aminoimidazoazaarene mutagens 
ranging 4.8 million-fold in mutagenic potency.  Revertant colonies in Salmonella strain 
TA98 per nanomole are given.
Figure 2. Mutagenic difference between two PhIP isomers. A: Mutagenic potency of 
PhIP (methyl group at the 1-posion) and 3-Me-PhIP. B: Metabolic activation scheme for 
PhIP. C: Formation of NOH-PhIP from PhIP and 3-me-PhIP isomers exposed to rat liver 
microsomes. D: Direct acting mutagenicity of NOH-PhIP and 3-me-NOH-PhIP in the 
Ames/Salmonella assay.  
Figure 3.  Cytotoxicity of NOH-PhIP in various CHO cell lines with mutant DNA repair 
genes.
Figure 4.  Linear relationship between LUMO energy and log mutagenic potency from 
QSAR involving 15 AIA mutagens.  Each point represents one AIA compound.  From 
this data extrapolation of the mutagenic potency of two proposed novel highly mutagenic 
heterocyclic amine analogs, with lower LUMO energies than any observed AIA, is 
shown.  A lower LUMO energy means higher electron affinity.
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